A study from Imperial College London and Lund University indicates that prescribing two inexpensive drugs, statins and ezetimibe, together could substantially lower the risk of subsequent heart attacks or strokes for cardiac patients. Currently, many patients are not receiving this combination, leading to preventable cardiovascular events and increased healthcare costs. Data analysis from over 36,000 patients demonstrated that those who received both drugs early post-heart attack had better outcomes. Researchers advocate for changes in treatment protocols to save lives and reduce healthcare burdens associated with cardiovascular diseases.
This study shows that we could save lives and reduce further heart attacks by giving patients a combination of two low-cost drugs.
Researchers found that by giving heart attack patients two drugs - statins and ezetimibe - together, their risk of another heart attack or stroke was significantly reduced.
Collection
[
|
...
]